Filing Details
- Accession Number:
- 0001628280-18-006899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-17 15:35:11
- Reporting Period:
- 2018-05-15
- Accepted Time:
- 2018-05-17 15:35:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640500 | Jennifer Balliet | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | Vp And Chief Culture Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-05-15 | 13,000 | $4.78 | 13,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-05-15 | 6,500 | $11.21 | 6,500 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-15 | 6,500 | $11.26 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-15 | 13,000 | $0.00 | 13,000 | $4.78 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
100,000 | 2016-05-04 | 2020-05-04 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $7.15 | 2017-04-20 | 2021-04-20 | 50,000 | 50,000 | Direct |
Common Stock | Restricted Stock | $0.00 | 2018-05-25 | 20,000 | 20,000 | Direct | |
Common Stock | Stock Option (Right to Buy) | $8.03 | 2019-02-26 | 2023-02-26 | 72,500 | 72,500 | Direct |
Common Stock | Stock Option (Right to Buy) | $7.52 | 2018-04-28 | 2022-04-28 | 60,000 | 60,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-04-20 | 50,000 | 50,000 | Direct |
20,000 | 20,000 | Direct | |
2023-02-26 | 72,500 | 72,500 | Direct |
2022-04-28 | 60,000 | 60,000 | Direct |
Footnotes
- On May 4, 2015, Jennifer Balliet was granted 120,000 stock options,these options vest ratably over the first three anniversary dates of the grant date. On March 26, 2018, 7,000 of these options were exercised leaving a balance of 113,000 options.
- On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- Restricted stock will vest as follows; 6,666 units will vest on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020.
- These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.
- On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date.
- On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.